Navigating liver cancer care: a study for patients, caregivers, and providers
Part of Cancer, Digestive system clinical trials.
This study aims to improve how patients with liver cancer (hepatocellular carcinoma) get the support and information they need. Researchers will interview patients, caregivers, and healthcare providers to find better ways to navigate care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (hepatocellular carcinoma) or are a caregiver, advocate, or healthcare provider involved in liver cancer care.
- You are 18 years or older.
- You speak English or Spanish.
- You are able to give your informed consent to participate.
- You do not have severe confusion or memory problems that would make it hard to take part in an interview.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to guide people with hepatocellular carcinoma (a type of liver cancer) through the study process. It may help you by explaining what to expect and supporting you in following required study steps.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This study tests a psychoeducational program to help patients with newly diagnosed liver cancer (HCC) learn about their condition and cope better. It aims to see if this support improves well-being.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.